Ms. Cornel is the Manager of the Biotherapeutics Quality Division 1 (BQD1) of the Biologics and Radiopharmaceutical Drugs Directorate at Health Canada. She earned her MSc in Biology at Queen’s University in 1994 and joined the BRDD soon after in the Research Services Division, where she participated in a number of diverse research projects focussed on biological drugs. In 2011, Fiona transitioned from research to the evaluation of the chemistry, manufacturing, and controls of various biotherapeutic products including monoclonal antibodies, hormones, enzymes, and cytokines. In 2020, she moved to a manager role in BQD1, which is responsible for the quality evaluation of biotherapeutics. Fiona is also an active member of the CASSS community, and began serving on the CMC Strategy Forum North America Committee in 2018.